John Caleb Browning Sr. MD

Dermatology•San Antonio, TX

Pediatric Dermatology

Assistant Professor, Pediatrics, University of Texas Medical School, San Antonio

Join to View Full Profile

3320 Oakwell CtSan Antonio, TX 78218
Phone+1 210-829-5180
Fax+1 210-829-5030

Summary

Dr. John Browning Sr., located in San Antonio, TX, is a dermatologist specializing in pediatric dermatology. He completed his fellowship in pediatric dermatology and residencies in dermatology and pediatrics at Baylor College of Medicine. Dr. Browning is experienced in general dermatology, dermatitis, psoriasis, pediatric dermatology, and eczema. He has been involved in multiple clinical trials and has several publications focusing on atopic dermatitis, alopecia areata, and related dermatological conditions. He is a Fellow (FAAD) of the American Academy of Dermatology.

Education & Training

Baylor College of MedicineResidency, Dermatology, 2004 - 2007
Baylor College of Medicine (Houston)Residency, Pediatrics, 2001 - 2004
University of Texas Medical Branch School of MedicineClass of 2001
Baylor College of MedicineFellowship, Pediatric Dermatology

Certifications & Licensure

TX State Medical License 2004 - 2027
American Board of Dermatology Dermatology
American Board of Dermatology Pediatric Dermatology
American Board of Pediatrics Pediatrics

Awards, Honors, & Recognition

Fellow (FAAD) American Academy of Dermatology

Clinical Trials

Timolol for the Prevention of Proliferation of Infantile Hemangioma (TiPPIH Trial) Start of enrollment: 2012 Jul 01
Terminated
Phase 1
A Trial of a Botanical Drug Containing East Indian Sandalwood Oil (EISO) for the Treatment of Molluscum Contagiosum Start of enrollment: 2016 Feb 01
Terminated
Phase 2
Mirvaso in Use Study Start of enrollment: 2014 Sep 01
Completed
Phase 4
A Study to Evaluate the Safety and Efficacy of CB-03-01 Cream, 1% in Subjects With Facial Acne Vulgaris (26) Start of enrollment: 2015 Nov 16
Completed
Phase 3
A Trial of a Botanical Drug Containing East Indian Sandalwood Oil (EISO) For Treatment of Atopic Dermatitis Start of enrollment: 2017 Apr 21
Completed
Phase 2
Phase III Efficacy and Safety Study of Oleogel-S10 in Epidermolysis Bullosa Start of enrollment: 2017 Mar 29
Completed
Phase 3
Study of Ixekizumab (LY2439821) in Children 6 to Less Than 18 Years With Moderate-to-Severe Plaque Psoriasis Start of enrollment: 2017 Mar 28
Completed
Phase 3
A Pharmacokinetic Study of Ruxolitinib Phosphate Cream in Pediatric Subjects With Atopic Dermatitis Start of enrollment: 2017 Sep 21
Completed
Phase 1
Effectiveness and Safety of BMS-986165 Compared to Placebo and Active Comparator in Participants With Psoriasis Start of enrollment: 2018 Aug 07
Completed
Phase 3
First in Human Trial of Topical VT30 in Pts With Venous/Lymphatic Malformations Assoc With PIK3CA or TEK Gene Mutations Start of enrollment: 2020 Oct 01
Terminated
Phase 1, Phase 2
Join now to see all

Publications & Presentations

PubMed

3 citations
Skin clearance, duration of treatment-free interval, and safety of tapinarof cream 1% once daily: Results from ADORING 3, a 48-week phase 3 open-label extension trial ...
Robert Bissonnette, Linda Stein Gold, Leon Kircik, Eric L Simpson, Lawrence F Eichenfield
Journal of the American Academy of Dermatology. 2025-09-01
Efficacy and Safety of Once-Daily Roflumilast Cream 0.05% in Pediatric Patients Aged 2-5 Years With Mild-to-Moderate Atopic Dermatitis (INTEGUMENT-PED): A Phase 3 Rand...
Lawrence F Eichenfield, Rocco Serrao, Vimal H Prajapati, John C Browning, Lisa Swanson
Pediatric Dermatology. 2025-02-20
1 citations
A Phase 1, Open-Label Study of the Pharmacokinetics of Ritlecitinib in Children Aged 6-12 Years With Alopecia Areata.
Mercedes E Gonzalez, John Browning, Stacy Smith, Anna Plotka, Jing Daisy Zhu
Pediatric Dermatology. 2025-02-09

Press Mentions

Texas Dermatologist Recognized for Improving the Quality of Life of a Child with Rare ConditionNovember 30th, 2022
Berdazimer Gel Beats Vehicle for Molluscum Contagiosum in Phase 3 StudyJuly 15th, 2022
Berdazimer Gel Beats Vehicle for Molluscum Contagiosum in Phase 3 StudyJuly 15th, 2022
Join now to see all

Professional Memberships

American Academy of Dermatology - AAD
Fellow

Other Languages

Spanish